Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AveXis Inc.

Division of Novartis AG
www.avexis.com

Latest From AveXis Inc.

US FDA Decides Against Zolgensma Data Integrity Penalties As Novartis Bureaucratizes AveXis

Company’s promise to be more forthright, along with quality culture and policy upgrades, may have helped sway agency.

Quality Enforcement

Zolgensma and Seven Other Products Get CHMP Thumbs Up

Zolgensma should receive a conditional approval, says the European Medicines Agency’s drug evaluation committee, the CHMP.

Europe Approvals

Novartis Close To EU Approval For Zolgensma At Last

Novartis’s AveXis unit has received a CHMP nod for the spinal muscular atrophy gene therapy at its latest meeting, sending it on the final steps to market in the EU.

Approvals Companies

Critical Juncture In Zolgensma EU Market Quest

If Zolgensma gets the thumbs up from the EMA this week, it will likely get formal EU approval within a couple of months. 

Europe BioPharmaceutical
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Macromolecule
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Novartis AG
  • Senior Management
  • David Lennon, PhD, Pres.
    Brian K Kaspar, PhD, CSO
    Andrew Knudten, SVP, Tech. Operations & CTO
    Rick Modi, SVP, CBO
    James J L’Italien, PhD, SVP, Chief Reg. & Quality Officer
  • Contact Info
  • AveXis Inc.
    Phone: (847) 572-8280
    2275 Half Day Rd.
    Ste. 200
    Bannockburn, IL 60015
    USA
UsernamePublicRestriction

Register